| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b2c49d16e6ecc729099d6f3589e7d79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84498ee3a3aff5b465695c063b71690b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35baa5e56b00925eb8e21a61bb61c76a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5105ab61c89f705cd1a33d1431adf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 |
| filingDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d741a2902a2622550d0c181e92dfcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_530a1ed621f099839ff76ba597a47c96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_138d8218de9a2a1a5ec03f445d458190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9ab50f6aec371f2ea4202faf56d6247 |
| publicationDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011060205-A1 |
| titleOfInvention |
Methods, compositions, and assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease |
| abstract |
An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. Also provided is an in vitro assay for determining the effect of an activated CD8 + T-cell on a sensitized melanoma cell. A method for improving the specific cytolytic activity (SCA) of an immune cell comprising contacting an immune cell with an antigen and an antigen-independent pro-inflammatory agent is provided. A method for ex vivo expansion of antigen-specific CD8 + T -cells with enhanced specific cytolytic activity (SCA) comprising culturing the antigen-specific CD8 + T-cells in a suitable culture media comprising an amino acid. An in vitro assay is provided for determining the effect of an immune cell on a cell from an infectious or neoplastic disease. A method of treating a subject suffering from an infectious or neoplastic disease with immuno therapy is described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102911918-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102911918-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113897333-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113897333-B |
| priorityDate |
2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |